Brandon Qualifies for the 1500m Semi-Finals – Competes July 8th

Brandon Hudgins, elite runner, and vasculitis patient, continues his quest to make the 2016 U.S. Olympic Team!  On Thursday, July 7th, Brandon qualified for the semi-finals of the 1500m race with a time of 3:43.25 during the Olympic Team Trials in Eugene, Oregon.  The semi-finals will be held on Friday, July 8th at 4:12 p.m. PST.  Please check the NBCSN website to find the broadcast times for the Men’s 1500m races.  Schedules are subject to change.


Brandon.Poster.2.signature.7.2016Support Brandon and the VF
In honor of qualifying for the 2016 U.S. Olympic Team Trials, the Vasculitis Foundation has created an exclusive poster showcasing Brandon’s grit and perseverance.  This 11×17 poster was designed by John Fries, a graphic artist in Pittsburgh.  Each poster is personally autographed by Brandon.

Proceeds will go directly to the VF to help its mission of raising vasculitis awareness, funding vasculitis research, and helping patients manage this serious disease. Click here to purchase.


Background
Elite runner, and vasculitis patient, Brandon Hudgins, has qualified to compete in the 2016 Olympic Trials in Eugene, Oregon, July 7-10.  Brandon will be competing in the Men’s 1500m races to hopefully become one of the three athletes chosen to represent the U.S. in this event at the 2016 Olympics in Rio in August.

Brandon poster image. FINAL
VF Team Brandon Press Release – June 2016

Visit the 2016 Olympic Games website

Visit the 2016 U.S. Olympic Team Trials – Track & Field

Follow Brandon in the Men’s 1500m Qualifying Races (USATF Schedule and Race Results) 


Brandon’s Race Schedule
Please check the USATF web page to confirm dates/times!
* 1st round 1500m:  July 7th, 7:21 p.m. PST
* 2nd round:  July 8th, 4:12 p.m. PST
* Final race:  July 10th, 5:20 p.m. PST

The 2016 U.S. Olympic Team Trials  Track & Field will be broadcast on NBC Sports.  Please check the NBCSN website to find the broadcast times for the Men’s 1500m races.

 

 

joinbuttonimage1_395x

Join a winning team! Sign up to get Brandon’s weekly Sweat/No Sweat challenge email.

 



 


20121120Hudgins,Brandon

The Vasculitis Foundation (VF) is pleased to announce that elite runner and vasculitis patient Brandon Hudgins yesterday became one of only 30 runners in the nation eligible to compete for a spot on the United States Olympic Team. The USATF trials take place July 1-10 in Eugene, Oregon.

“The Vasculitis Foundation could not be more proud of Brandon,” said Joyce A. Kullman, executive director of the Foundation. “To say that we’re excited about his reaching his goal is a huge understatement. We are his biggest cheerleaders.”

This spring the Foundation partnered with Hudgins to launch “Victory Over Vasculitis: VF Team Brandon,” an initiative designed to support his efforts to increase awareness of his rare, autoimmune disease while attempting to qualify for the Olympic Team. The Vasculitis Foundation is committed to improving the lives of current and future patients and serves as the definitive resource for those seeking information about vasculitis. 

“Through Brandon’s ongoing athletic training and boundless energy as an advocate for vasculitis awareness,” says Kullman, “he exemplifies our philosophy that patients with autoimmune diseases can live rich, full lives.” She notes that, since 1986, the Vasculitis Foundation has empowered patients through disease education, raising awareness of vasculitis in the general public and medical community, and funding research to determine the cause, develop more effective treatments, and discover a cure.

Hudgins, 28, a native of Rock Hill, S.C. who began running competitively as a high school student, holds a Bachelor’s degree in Physical Education: Fitness and Wellness from Winthrop University and a Master’s in Exercise Science: Strength and Conditioning from Appalachian State University. His illness was diagnosed in 2008 following a seven-month struggle with severe sinus symptoms.

Last summer, Hudgins became only the 448th American to run a mile in less than 4-minutes when he completed the Sir Walter Miler in Raleigh, N.C. in 3:59.67. At the time, Runner’s World wrote that he was most likely the first to do so after overcoming granulomatosis with polyangitis (GPA), a rare autoimmune disease that affects the blood vessels, and quoted him as saying that, “If you want something badly enough and have the courage to chase your dreams, you have to be willing to walk through the dark places to get them.”

Partnering With the Vasculitis Foundation

A passionate advocate for vasculitis awareness, Hudgins formed a partnership with the VF this year because he wants to help raise awareness among the medical community and the public about  the needs and challenges facing all patients with autoimmune vasculitis. Through the campaign “Victory Over Vasculitis: VF Team Brandon,” Hudgins leverages his public profile to create awareness of autoimmune diseases.

As part of the campaign, Hudgins invites the public to become involved in VF Team Brandon’s Virtual 100K challenge. In addition to supporting his Olympic training, the team has set a goal to run collectively or walk 100,000 miles by the end of 2016. To date, more than (Number) people from around the world have joined the team. Each member is asked to log his or her weekly miles, which are counted toward the grand goal. There is no cost for participating. More information is available at www.vasculitisfoundation.org.

 

Upcoming Races

In addition to competing in the USATF Olympic Team Trials, Brandon plans to take part in the Sir Walter Miler in Raleigh, North Carolina (August 5), the West Chester Road Mile in West Chester, Pennsylvania (August 11), the Liberty Mile in Pittsburgh, Pennsylvania (August 26), and Grandma’s Minnesota Mile in Duluth, Minnesota (September 11).

Vasculitis Foundation

The Vasculitis Foundation is the international organization for patients with vasculitis, their families, friends and the health care professionals who care for them.


Introducing our 2017-2018 VCRC-VF Fellow

Kaitlin Quinn, MD, is the recipient of the 2017 VCRC-VF Fellowship.  She received her medical degree from New York Medical College in Valhalla, New York.   She completed her Internal Medicine more »

FDA Approves Genentech’s Actemra® for Giant Cell Arteritis

Genentech, a member of the Roche Group, announced today (May 22, 2017) that the U.S. Food and Drug Administration (FDA) has approved Actemra® (tocilizumab) subcutaneous injection for the treatment of more »

Brandon Hudgins to Receive NORD Rare Impact Award at May 18th Ceremony

On  Thursday, May 18,  Brandon Hudgins will be accepting the NORD 2017 Rare Impact Award.   The VF  nominated Brandon, a record-breaking, elite runner, for his work raising awareness about more »


Vasculitis Update 2017 CME Course: Chicago, June 24

The Vasculitis Foundation is pleased to present the 2017 Vasculitis Update CME Course for health care professionals in partnership with Northwestern Division of Rheumatology on Saturday, June 24, 2017 from 7:45 more »

Main Line Health Medical Professional Wins National Award for Early Diagnosis of Rare Disease

The Vasculitis Foundation (VF) announces the winner of its 2017 Recognizing Excellence in Diagnostics (RED) Award.  The V-RED Award is presented annually to a medical professional who made a quick diagnosis of more »